Harford Bank
OTC:HFBK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harford Bank
OTC:HFBK
|
US |
|
O
|
Ottakringer Getraenke AG
VSE:OTV
|
AT |
|
I
|
Incannex Healthcare Ltd
NASDAQ:IXHL
|
AU |
|
Nusco SpA
MIL:NUS
|
IT |
|
Cavendish Financial PLC
LSE:CAV
|
UK |
|
Mirle Automation Corp
TWSE:2464
|
TW |
|
I
|
Intops Co Ltd
KOSDAQ:049070
|
KR |
|
Zignago Vetro SpA
MIL:ZV
|
IT |
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
TW |
Cash Flow Statement
Cash Flow Statement
Harford Bank
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
5
|
6
|
6
|
6
|
6
|
7
|
7
|
7
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
2
|
(1)
|
(1)
|
(1)
|
0
|
|
| Change in Working Capital |
(1)
|
(0)
|
1
|
0
|
1
|
1
|
0
|
(0)
|
|
| Cash from Operating Activities |
7
N/A
|
7
+10%
|
9
+19%
|
9
+2%
|
7
-22%
|
7
-3%
|
7
+2%
|
7
+7%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(76)
|
(90)
|
(92)
|
(94)
|
(66)
|
(22)
|
19
|
18
|
|
| Cash from Investing Activities |
(76)
N/A
|
(90)
-18%
|
(93)
-3%
|
(94)
-2%
|
(66)
+30%
|
(22)
+67%
|
19
N/A
|
18
-5%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash Paid for Dividends |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
17
|
6
|
11
|
13
|
64
|
67
|
51
|
42
|
|
| Cash from Financing Activities |
16
N/A
|
5
-69%
|
9
+99%
|
12
+27%
|
63
+423%
|
66
+5%
|
49
-25%
|
40
-19%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
(54)
N/A
|
(78)
-45%
|
(74)
+5%
|
(73)
+1%
|
4
N/A
|
51
+1 320%
|
75
+49%
|
66
-13%
|
|